2021
DOI: 10.1089/ten.teb.2020.0181
|View full text |Cite
|
Sign up to set email alerts
|

Innovative Molecular and Cellular Therapeutics in Cleft Palate Tissue Engineering

Abstract: Clefts of the lip and/or palate are the most prevalent orofacial birth defects occurring in about 1:700 live human births worldwide. Early postnatal surgical interventions are extensive and staged to bring about optimal growth and fusion of palatal shelves. Severe cleft defects pose a challenge to correct with surgery alone, resulting in complications and sequelae requiring life-long, multidisciplinary care. Advances made in materials science innovation, including scaffold-based delivery systems for precision … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 271 publications
(250 reference statements)
0
11
0
Order By: Relevance
“…Therefore, it is of significant clinical importance to explore the pathogenesis of cleft lip and palate. Since morphological events in mice closely resemble those seen in humans, mouse genetic models with palatal defects have been valuable for analyzing the genes that regulate palatogenesis and for determining the genetic causes of human cleft palate (Oliver et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is of significant clinical importance to explore the pathogenesis of cleft lip and palate. Since morphological events in mice closely resemble those seen in humans, mouse genetic models with palatal defects have been valuable for analyzing the genes that regulate palatogenesis and for determining the genetic causes of human cleft palate (Oliver et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…The RNA-seq results suggested the stimulating effect of wild-type VEGFA on osteoblast differentiation was higher than that of mutant type, indicating that the mutation has a negative influence on osteogenesis. Oliver et al [ 37 ] also revealed that the tissue engineering scaffold of osteogenic growth factor is involved in regulating the molecular signal network related to driving the occurrence of CL/P, providing a new way for the CL/P surgical correction operation site to stimulate bone formation.…”
Section: Discussionmentioning
confidence: 99%
“…ECMs can serve conceptually similar roles controlling tissue development and homeostasis, as well as organ-specific mechanisms. Many questions remain unanswered, providing rich opportunities for future research and therapy (e.g., see Oliver et al 2021).…”
Section: Discussionmentioning
confidence: 99%